Susann Szmania

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

Eric D. Hsi, Roxanne Steinle, Balaji Balasa et al. · Clinical Cancer Research · 2008 · 555 citations · Full text

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Natalia Lapteva, April Durett, Jiali Sun et al. · Cytotherapy · 2012 · 202 citations · Full text

Cell Therapy, Adaptive Immune System, Immunology +5

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Frits van Rhee, Susann Szmania, Fenghuang Zhan et al. · Blood · 2005 · 192 citations · Full text

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

Jumei Shi, Guido Tricot, Susann Szmania et al. · British Journal of Haematology · 2008 · 191 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +14

Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients

Susann Szmania, Natalia Lapteva, Tarun K. Garg et al. · Journal of Immunotherapy · 2014 · 179 citations · Full text

Cell Therapy, Immunology, Immunoediting +23